Procarbazine

Common Name

Procarbazine Description

Procarbazine is only found in individuals that have used or taken this drug. It is an antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkins disease. [PubChem]The precise mode of cytotoxic action of procarbazine has not been clearly defined. There is evidence that the drug may act by inhibition of protein, RNA and DNA synthesis. Studies have suggested that procarbazine may inhibit transmethylation of methyl groups of methionine into t-RNA. The absence of functional t-RNA colid cause the cessation of protein synthesis and consequently DNA and RNA synthesis. In addition, procarbazine may directly damage DNA. Hydrogen peroxide, formed during the auto-oxidation of the drug, may attack protein slifhydryl groups contained in residual protein which is tightly bound to DNA. Structure

Synonyms

Value Source 1-Methyl-2-(P-(isopropylcarbamoyl)benzyl)hydrazineChEBI 2-(P-Isopropylcarbamoylbenzyl)-1-methylhydrazineChEBI 4-((2-methylhydrazino)Methyl)-N-isopropylbenzamideChEBI N-(1-Methylethyl)-4-((2-methylhydrazino)methyl)benzamideChEBI N-4-Isopropylcarbamoylbenzyl-n'-methylhydrazineChEBI N-Isopropyl-4-[(2-methylhydrazino)methyl]benzamideChEBI N-Isopropyl-alpha-(2-methylhydrazino)-P-toluamideChEBI N-Isopropyl-P-(2-methylhydrazinomethyl)-benzamideChEBI P-(2-Methylhydrazinomethyl)-N-isopropylbenzamideChEBI ProcarbazinChEBI ProcarbazinaChEBI ProcarbazinumChEBI N-Isopropyl-a-(2-methylhydrazino)-P-toluamideGenerator N-Isopropyl-α-(2-methylhydrazino)-P-toluamideGenerator IbenzmethyzinHMDB IbenzmethyzineHMDB IBZHMDB MBHHMDB MIHHMDB PCXHMDB Cambridge laboratories brand OF procarbazine hydrochlorideMeSH Procarbazine monohydrobromideMeSH Procarbazine monohydrochlorideMeSH Monohydrochloride, procarbazineMeSH MatlianeMeSH Monohydrobromide, procarbazineMeSH NatlianMeSH Roche brand OF procarbazine hydrochlorideMeSH Hydrochloride, procarbazineMeSH Procarbazine hydrochlorideMeSH Sigma tau brand OF procarbazine hydrochlorideMeSH Sigma-tau brand OF procarbazineMeSH Sigma-tau brand OF procarbazine hydrochlorideMeSH

Chemical Formlia

C12H19N3O Average Molecliar Weight

221.2988 Monoisotopic Molecliar Weight

221.152812245 IUPAC Name

4-[(2-methylhydrazin-1-yl)methyl]-N-(propan-2-yl)benzamide Traditional Name

procarbazine CAS Registry Number

671-16-9 SMILES

CNNCC1=CC=C(C=C1)C(=O)NC(C)C

InChI Identifier

InChI=1S/C12H19N3O/c1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3/h4-7,9,13-14H,8H2,1-3H3,(H,15,16)

InChI Key

CPTBDICYNRMXFX-UHFFFAOYSA-N Chemical Taxonomy Description

This compound belongs to the class of organic compounds known as benzamides. These are organic compounds containing a carboxamido substituent attached to a benzene ring. Kingdom

Organic compounds Super Class

Benzenoids Class

Benzene and substituted derivatives Sub Class

Benzoic acids and derivatives Direct Parent

Benzamides Alternative Parents

  • Benzoyl derivatives
  • Secondary carboxylic acid amides
  • Alkylhydrazines
  • Organopnictogen compounds
  • Organooxygen compounds
  • Organic oxides
  • Hydrocarbon derivatives
  • Substituents

  • Benzamide
  • Benzoyl
  • Secondary carboxylic acid amide
  • Carboxamide group
  • Alkylhydrazine
  • Carboxylic acid derivative
  • Organic nitrogen compound
  • Organic oxygen compound
  • Organopnictogen compound
  • Organic oxide
  • Hydrocarbon derivative
  • Organooxygen compound
  • Organonitrogen compound
  • Hydrazine derivative
  • Aromatic homomonocyclic compound
  • Molecliar Framework

    Aromatic homomonocyclic compounds External Descriptors

  • benzamides (CHEBI:71417 )
  • hydrazines (CHEBI:71417 )
  • Ontology Status

    Expected but not Quantified Origin

  • Drug
  • Biofunction

  • Antineoplastic Agents
  • Application

  • Pharmaceutical
  • Cellliar locations

  • Cytoplasm
  • Membrane
  • Physical Properties State

    Solid Experimental Properties

    Property Value Reference Melting Point223 °CNot Available Boiling PointNot AvailableNot Available Water Solubility2.28e-01 g/LNot Available LogP2.6Not Available

    Predicted Properties

    Property Value Source Water Solubility0.23 mg/mLALOGPS logP0.53ALOGPS logP0.99ChemAxon logS-3ALOGPS pKa (Strongest Acidic)15.03ChemAxon pKa (Strongest Basic)5.6ChemAxon Physiological Charge0ChemAxon Hydrogen Acceptor Count3ChemAxon Hydrogen Donor Count3ChemAxon Polar Surface Area53.16 Å2ChemAxon Rotatable Bond Count5ChemAxon Refractivity86.98 m3·mol-1ChemAxon Polarizability25.88 Å3ChemAxon Number of Rings1ChemAxon Bioavailability1ChemAxon Rlie of FiveYesChemAxon Ghose FilterYesChemAxon Vebers RlieYesChemAxon MDDR-like RlieYesChemAxon

    Spectra Spectra

    Spectrum Type Description Splash Key LC-MS/MS

    LC-MS/MS Spectrum – , positivesplash10-0096-0910000000-161c214dc9eb9c75895bView in MoNA Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 10V, PositiveNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 20V, PositiveNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 40V, PositiveNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 10V, NegativeNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 20V, NegativeNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 40V, NegativeNot Available MS

    Mass Spectrum (Electron Ionization)splash10-016u-6900000000-6488b097a4640e8af61aView in MoNA

    Biological Properties Cellliar Locations

  • Cytoplasm
  • Membrane
  • Biofluid Locations

  • Blood
  • Urine
  • Tissue Location

    Not Available Pathways

    Not Available Normal Concentrations

    Biofluid Status Value Age Sex Condition Reference Details BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB01168

  • 21059682
  • details UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB01168

  • 21059682
  • details

    Abnormal Concentrations

    Not Available Predicted Concentrations

    Biofluid Value Original age Original sex Original condition Comments Blood0-5 uMAdlit (>18 years old)BothNormalPredicted based on drug qualities Blood0-2 umol/mmol creatinineAdlit (>18 years old)BothNormalPredicted based on drug qualities

    Associated Disorders and Diseases Disease References

    None Associated OMIM IDs

    None External Links DrugBank ID

    DB01168 DrugBank Metabolite ID

    Not Available Phenol Explorer Compound ID

    Not Available Phenol Explorer Metabolite ID

    Not Available FoodDB ID

    Not Available KNApSAcK ID

    Not Available Chemspider ID

    4746 KEGG Compound ID

    C07402 BioCyc ID

    Not Available BiGG ID

    Not Available Wikipedia Link

    Procarbazine NuGOwiki Link

    HMDB15299 Metagene Link

    HMDB15299 METLIN ID

    Not Available PubChem Compound

    4915 PDB ID

    Not Available ChEBI ID

    366225

    Product: AMPPD

    References Synthesis Reference Not Available Material Safety Data Sheet (MSDS) Not Available General References Not Available

    Enzymes

    General function:
    Involved in oxidoreductase activity
    Specific function:
    Key enzyme in purine degradation. Catalyzes the oxidation of hypoxanthine to xanthine. Catalyzes the oxidation of xanthine to uric acid. Contributes to the generation of reactive oxygen species. Has also low oxidase activity towards aldehydes (in vitro).
    Gene Name:
    XDH
    Uniprot ID:
    P47989
    Molecular weight:
    146422.99
    General function:
    Involved in monooxygenase activity
    Specific function:
    Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.Participates in the metabolism of an as-yet-unknown biologically active molecule that is a participant in eye development.
    Gene Name:
    CYP1B1
    Uniprot ID:
    Q16678
    Molecular weight:
    60845.33
    References
    1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]

    PMID: 11118147